TRIM21 and inclusion body myositis: Owing to the discovery of concurrent identification of anti-Ro-52 and anti-NT5c1A antibodies, a hypothesis has been proposed regarding the pathophysiological relationship between the two in patients with IBM; however, this was insufficient to prove an association [4].